226 related articles for article (PubMed ID: 34127007)
1. Radiofrequency ablation versus repeat hepatectomy in the treatment of recurrent hepatocellular carcinoma in subcapsular location: a retrospective cohort study.
Wei F; Huang Q; Zhou Y; Luo L; Zeng Y
World J Surg Oncol; 2021 Jun; 19(1):175. PubMed ID: 34127007
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
[TBL] [Abstract][Full Text] [Related]
3. Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial.
Xia Y; Li J; Liu G; Wang K; Qian G; Lu Z; Yang T; Yan Z; Lei Z; Si A; Wan X; Zhang H; Gao C; Cheng Z; Pawlik TM; Wang H; Lau WY; Wu M; Shen F
JAMA Oncol; 2020 Feb; 6(2):255-263. PubMed ID: 31774468
[TBL] [Abstract][Full Text] [Related]
4. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
[TBL] [Abstract][Full Text] [Related]
5. Optimal treatment strategy for recurrent hepatocellular carcinoma based on recurrence time and tumor size: A propensity score matching study.
Wan W; Zhang H; Ji T; Zhang L; Luo K; Xiong D
Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102157. PubMed ID: 37321321
[TBL] [Abstract][Full Text] [Related]
6. Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrence.
Wang C; Li K; Huang Z; Yuan Y; He W; Zheng Y; Zou R; Li B; Yuan Y; Qiu J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15113-15125. PubMed ID: 37632543
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis.
Zhou Q; Wang X; Li R; Wang C; Wang J; Xie X; Li Y; Li S; Mao X; Liang P
J Gastroenterol; 2022 Sep; 57(9):684-694. PubMed ID: 35816221
[TBL] [Abstract][Full Text] [Related]
8. Repeat hepatic resection combined with intraoperative radiofrequency ablation versus repeat hepatic resection alone for recurrent and multiple hepatocellular carcinoma patients meeting the Barcelona Clinic Liver Cancer stage A: A propensity score-matched analysis.
Huang Y; Xu L; Huang M; Jiang L; Xu M
Cancer Med; 2023 Apr; 12(8):9213-9227. PubMed ID: 36722129
[TBL] [Abstract][Full Text] [Related]
9. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.
Lin CH; Ho CM; Wu CH; Liang PC; Wu YM; Hu RH; Lee PH; Ho MC
Surg Endosc; 2020 Dec; 34(12):5566-5573. PubMed ID: 31993821
[TBL] [Abstract][Full Text] [Related]
10. Repeat hepatectomy versus radiofrequency ablation in management of recurrent hepatocellular carcinoma: an average treatment effect analysis.
Chua DW; Koh YX; Syn NL; Chuan TY; Yao TJ; Lee SY; Goh BKP; Cheow PC; Chung AY; Chan CY
Ann Surg Oncol; 2021 Nov; 28(12):7731-7740. PubMed ID: 33969464
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation versus hepatic resection for recurrent hepatocellular carcinoma: an updated meta-analysis.
Yang D; Zhuang B; Wang Y; Xie X; Xie X
BMC Gastroenterol; 2020 Nov; 20(1):402. PubMed ID: 33246417
[TBL] [Abstract][Full Text] [Related]
12. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
[TBL] [Abstract][Full Text] [Related]
14. Combined radiofrequency ablation and ethanol injection versus repeat hepatectomy for elderly patients with recurrent hepatocellular carcinoma after initial hepatic surgery.
Chen S; Peng Z; Xiao H; Lin M; Chen Z; Jiang C; Hu W; Xie X; Liu L; Peng B; Kuang M
Int J Hyperthermia; 2018 Nov; 34(7):1029-1037. PubMed ID: 28974113
[TBL] [Abstract][Full Text] [Related]
15. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
[TBL] [Abstract][Full Text] [Related]
16. Surgical resection versus radiofrequency ablation for early recurrent hepatocellular carcinoma.
Shi T; Xu C; Feng Y; Wei Y; Lv H; Zhu Q
Eur J Gastroenterol Hepatol; 2022 Aug; 34(8):844-851. PubMed ID: 35694799
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation
Conticchio M; Inchingolo R; Delvecchio A; Laera L; Ratti F; Gelli M; Anelli F; Laurent A; Vitali G; Magistri P; Assirati G; Felli E; Wakabayashi T; Pessaux P; Piardi T; di Benedetto F; de'Angelis N; Briceño J; Rampoldi A; Adam R; Cherqui D; Aldrighetti LA; Memeo R
World J Gastroenterol; 2021 May; 27(18):2205-2218. PubMed ID: 34025074
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation of subcapsular versus nonsubcapsular hepatocellular carcinomas ≤ 3 cm: analysis of long-term outcomes from two large-volume liver centers.
Han K; Kim JH; Kim GH; Kim JH; Kim SY; Park SH; Moon S; Kwon JH; Kim GM; Lee SJ; Won HJ; Shin YM
Eur Radiol; 2024 Mar; 34(3):1578-1586. PubMed ID: 37646813
[TBL] [Abstract][Full Text] [Related]
19. Repeat hepatic resection VS radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma: an updated meta-analysis.
Liu J; Zhao J; Gu HAO; Zhu Z
Minim Invasive Ther Allied Technol; 2022 Mar; 31(3):332-341. PubMed ID: 33143517
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation versus laparoscopic hepatectomy for hepatocellular carcinoma: A real world single center study.
Pan YX; Long Q; Yi MJ; Chen JB; Chen JC; Zhang YJ; Xu L; Chen MS; Zhou ZG
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):548-559. PubMed ID: 31677940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
